
Neurogene Releases Q3 2025 Financial Results and Updates
Neurogene Reports Third Quarter 2025 Financial Results and Provides Comprehensive Clinical and Corporate Updates a clinical-stage biotechnology company dedicated to delivering transformative genetic medicines for patients with rare neurological disorders,…












